| Financial Year |
March 31 2023 |
| Monetary Funds |
1,094,491,236.89 |
| Held-for-trading Financial Assets |
599,407,178.09 |
| Notes Receivable |
972,650,071.43 |
| Accounts Receivable |
720,077,445.42 |
| Advances to Suppliers |
228,813,984.96 |
| Other Receivables |
17,935,327.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,895,631,485.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,635,743.02 |
| Total Current Assets |
5,654,354,127.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,370,722.21 |
| Investment Properties |
-- |
| Fixed Assetes |
839,059,956.87 |
| Under-construction Projects |
196,740,265.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,241,237.58 |
| R&D expenses |
-- |
| Goodwill |
50,554,296.99 |
| Long-Term Deferred and Prepaid Expenses |
9,047,496.88 |
| Deferred Income Tax Assets |
42,682,932.41 |
| Other Non-Current Assets |
61,026,843.79 |
| Sub-Total of Non-Current Assets |
1,451,509,740.06 |
| Total Assets |
7,105,863,867.11 |
| Short-Term Loans |
131,266,869.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
657,689,393.56 |
| Accounts Payable |
583,898,376.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,863,318.94 |
| Taxes Payable |
15,106,253.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
277,087,977.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,910,111.07 |
| Other Current Liabilities |
303,359,681.12 |
| Sub-Total of Current Liabilities |
3,662,947,980.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,307,122.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
63,552,306.06 |
| Total Liabilities |
3,726,500,286.14 |
| Paid-In Capital(Or Share Stock) |
1,487,706,540.00 |
| Capital Surplus |
822,326,790.96 |
| Surplus Reserve |
104,488,166.42 |
| LESS:Treasury Stock |
70,099,797.21 |
| Undistributed Profits |
1,017,851,529.30 |
| Minority Stockholder's Interest |
17,290,394.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,362,073,186.66 |
| Owner's Equity（Stockholder's Equity） |
3,379,363,580.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,105,863,867.11 |
